Company: BLNE
Filing Date: 2025-03-27
Form Type: 424B7
Source: 0001641172-25-000822
Chunk: 13

Company: Beeline Holdings, Inc.
Filing Date: 2025-03-27
Form: 424B7
Chunk 13
---
 that are lower than these conversion and exercise prices, these conversion prices will automatically be lowered to the new lower sale price. This would cause additional dilution to our common stockholders and result in our receiving less cash upon exercise of warrants. Additionally, because the Company hopes to avoid such an outcome, our ability to raise capital under the ELOC will be limited to the extent our common stock trades near or below these prices.

By virtue of the terms of the Purchase Agreement, it is not possible to predict the number of shares we will sell nor the prices at which we will sell the shares under the Purchase Agreement, nor the consequences (including dilution to existing shareholders) which may result therefrom.

We may not be able to access sufficient funds under the Purchase Agreement with C/M when needed.

Our ability to sell shares to C/M and obtain funds under the Purchase Agreement is limited by the terms and conditions in the Purchase Agreement, including restrictions on when we may sell shares to C/M, restrictions on the amounts we may sell to C/M at any one time, and a limitation on our ability to sell shares to C/M to the extent that it would cause C/M to beneficially own more than 4.99% of our outstanding common stock. In addition, any amounts we sell under the Purchase Agreement may not satisfy all of our funding needs, even if we are able and choose to sell all $10,000,000 under the Purchase Agreement. The sale of the full $10,000,000 could also be further delayed by our need to file a subsequent registration statement on Form S-1 and have such registration statement to be declared effective by the SEC in order to make further sales beyond the up to $3,500,000 being offered hereby and the up to $4,000,000 under the prior prospectus supplements filed on March 10, 2025 and March 26, 2025 relating to shares issuable under the Purchase Agreement. If we elect to issue and sell more than the shares offered under this prospectus supplement to C/M, which we have the right, but not the obligation, to do, we must first register for resale under the Securities Act any such additional shares.

| S-16 |

We elected to enter into the Purchase Agreement with C/M as a means to access capital quickly as market conditions permit. The extent we rely on C/M as a source of funding will depend on a number of factors including, the prevailing market price and trading volume of our common stock and the extent to which we are